6326-77-8

Usage

Uses

Used in Pharmaceutical Industry:
5-CYCLOHEXYL-5-METHYLIMIDAZOLIDINE-2,4-DIONE is used as an antioxidant and anti-anxiety medication for the treatment of various neurological disorders due to its neuroprotective and anxiolytic properties.
Used in Neurological Disorders Treatment:
5-CYCLOHEXYL-5-METHYLIMIDAZOLIDINE-2,4-DIONE is used as a therapeutic agent for the treatment of neurological disorders, leveraging its potential anti-inflammatory and anti-ischemic effects to provide relief and improve patient outcomes.
Used in Research and Development:
5-CYCLOHEXYL-5-METHYLIMIDAZOLIDINE-2,4-DIONE is utilized in research settings to explore its unique structure and pharmacological properties, with the aim of discovering new therapeutic applications and enhancing its potential use in medicine.

InChI:InChI=1/C10H16N2O2/c1-10(7-5-3-2-4-6-7)8(13)11-9(14)12-10/h7H,2-6H2,1H3,(H2,11,12,13,14)

Upstream product

• 823-76-7 Cyclohexyl methyl ketone 
• 6843-49-8 5-methyl-5-phenylimidazolidin-2,4-dione 
• 151-50-8 potassium cyanide 

Downstream Products

• 6635-13-8 (R,S)-2-Amino-2-cyclohexylpropionic acid 

Relevant academic research and scientific papers

COMPOUNDS USEFUL AS MODULATORS OF TRPM8

The present invention includes compounds useful as modulators of TRPM8, such as compounds of Formulae (Ia), (Ib) and (Ic), and the subgenus and species thereof; personal products containing those compounds; and the use of those compounds and the personal products, particularly the use of increasing or inducing chemesthetic sensations, such as cooling or cold sensations.

N-SUBSTITUTED HETEROCYCLIC DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS IN WHICH THEY ARE PRESENT

The invention relates to N-substituted heterocyclic derivatives and its salts. These derivatives have the formula (I) in which the substituents are as defined in the specification. Application: Angiotensin II antagonists

N-SUBSTITUTED HETEROCYCLIC DERIVATIVES USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISORDERS

The present invention relates to N-substituted heterocyclic derivatives of formula: STR1 processes for their preparation, and pharmaceutical compositions which contain them. The compounds according to the invention are non-peptide compounds which oppose the action of angiotensin II. The compounds according to the invention are thus useful in the treatment of cardiovascular disorders such as hypertension and heart failure.

Dinitrogen heterocyclic derivatives N-substituted by a biphenylmethyl group, and the pharmaceutical compositions in which they are present

This invention relates to compounds of formula STR1 in which: R1 and R2 are similar or different and are each independently hydrogen or a group selected from CO2 N=C(NH2)2, CONHNHCONH2, CONHNHCSNH2, C(OC2 H5)=NCO2 CH3, COCH2 CO2 H5, N(OH)-CONHCOOC2 NCO2 CH3, COCH2 CO2 H5, N(OH)-CONHCOOC2 H5, C(OC2 H5)=NH or a nitrogen heterocycle; with the proviso that at least one of the substituents R1 or R2 is other than hydrogen; R3 is a hydrogen, a C1 -C6 alkyl, a C2 -C6 alkenyl, a C3 -C7 cycloalkyl, a phenyl, a phenylalkyl, or a phenylalkenyl; R4 and R5 are each independently a C1 -C6 alkyl, a C3 -C7 cycloalkyl, a phenyl or a phenylalkyl; or R4 and R5, bonded together, are either a group of the formula (CH2)n or a group of the formula (CH2)p Y (CH2)q, in which Y is either an oxygen atom, or a sulfur atom, or a substituted carbon atom, or a group N-R6, in which R6 is a hydrogen, a C1 -C4 alkyl, a phenylalkyl, a C1 -C4 alkylcarbonyl, a C1 -C4 halogenoalkylcarbonyl, a C1 -C4 polyhalogenoalkylcarbonyl, a benzolyl, an α-aminoacyl or a N-protecting group, or R4 and R5, together with the carbon atom to which they are bonded, form an indane or an adamantine; p+q=m; n is an integer between 2 and 11; m is an integer between 2 and 5; X is an oxygen or a sulfur atom; and z and t are zero or z+t=1; and its salts.

Hydantoin diglycidyl compounds

Hydantoin diglycidyl compounds of the formula STR1 wherein R1 is hydrogen, alkyl containing 1 to 8 carbon atoms or cycloalkyl containing 5 to 6 carbon atoms; and R2 is alkyl containing 5 to 8 carbon atoms or cycloalkyl containing 5 to 6 carbon atoms, are prepared. The diglycidyl compounds are liquid at room temperature, easily processable as casting and laminating resins and when cured possess excellent resistance to water.